338 related articles for article (PubMed ID: 12796197)
1. Detection of lung cancer with volatile markers in the breath.
Phillips M; Cataneo RN; Cummin AR; Gagliardi AJ; Gleeson K; Greenberg J; Maxfield RA; Rom WN
Chest; 2003 Jun; 123(6):2115-23. PubMed ID: 12796197
[TBL] [Abstract][Full Text] [Related]
2. Volatile markers of breast cancer in the breath.
Phillips M; Cataneo RN; Ditkoff BA; Fisher P; Greenberg J; Gunawardena R; Kwon CS; Rahbari-Oskoui F; Wong C
Breast J; 2003; 9(3):184-91. PubMed ID: 12752626
[TBL] [Abstract][Full Text] [Related]
3. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
[TBL] [Abstract][Full Text] [Related]
4. Prediction of lung cancer using volatile biomarkers in breath.
Phillips M; Altorki N; Austin JH; Cameron RB; Cataneo RN; Greenberg J; Kloss R; Maxfield RA; Munawar MI; Pass HI; Rashid A; Rom WN; Schmitt P
Cancer Biomark; 2007; 3(2):95-109. PubMed ID: 17522431
[TBL] [Abstract][Full Text] [Related]
5. Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.
Phillips M; Bauer TL; Cataneo RN; Lebauer C; Mundada M; Pass HI; Ramakrishna N; Rom WN; Vallières E
PLoS One; 2015; 10(12):e0142484. PubMed ID: 26698306
[TBL] [Abstract][Full Text] [Related]
6. Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry.
Ligor M; Ligor T; Bajtarevic A; Ager C; Pienz M; Klieber M; Denz H; Fiegl M; Hilbe W; Weiss W; Lukas P; Jamnig H; Hackl M; Buszewski B; Miekisch W; Schubert J; Amann A
Clin Chem Lab Med; 2009; 47(5):550-60. PubMed ID: 19397483
[TBL] [Abstract][Full Text] [Related]
7. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
8. Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).
Phillips M; Boehmer JP; Cataneo RN; Cheema T; Eisen HJ; Fallon JT; Fisher PE; Gass A; Greenberg J; Kobashigawa J; Mancini D; Rayburn B; Zucker MJ
J Heart Lung Transplant; 2004 Jun; 23(6):701-8. PubMed ID: 15366430
[TBL] [Abstract][Full Text] [Related]
9. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia.
Moretti M; Phillips M; Abouzeid A; Cataneo RN; Greenberg J
Am J Obstet Gynecol; 2004 May; 190(5):1184-90. PubMed ID: 15167816
[TBL] [Abstract][Full Text] [Related]
10. Breath markers of oxidative stress in patients with unstable angina.
Phillips M; Cataneo RN; Greenberg J; Grodman R; Salazar M
Heart Dis; 2003; 5(2):95-9. PubMed ID: 12713676
[TBL] [Abstract][Full Text] [Related]
11. A volatile biomarker in breath predicts lung cancer and pulmonary nodules.
Phillips M; Bauer TL; Pass HI
J Breath Res; 2019 Jun; 13(3):036013. PubMed ID: 31085817
[TBL] [Abstract][Full Text] [Related]
12. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
13. Comparison of volatile organic compounds from lung cancer patients and healthy controls-challenges and limitations of an observational study.
Schallschmidt K; Becker R; Jung C; Bremser W; Walles T; Neudecker J; Leschber G; Frese S; Nehls I
J Breath Res; 2016 Oct; 10(4):046007. PubMed ID: 27732569
[TBL] [Abstract][Full Text] [Related]
14. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
15. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
16. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
17. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
18. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
19. Volatile biomarkers in the breath of women with breast cancer.
Phillips M; Cataneo RN; Saunders C; Hope P; Schmitt P; Wai J
J Breath Res; 2010 Jun; 4(2):026003. PubMed ID: 21383471
[TBL] [Abstract][Full Text] [Related]
20. Effect of age on the profile of alkanes in normal human breath.
Phillips M; Greenberg J; Cataneo RN
Free Radic Res; 2000 Jul; 33(1):57-63. PubMed ID: 10826921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
